Production (Stage)
Conduit Pharmaceuticals Inc.
CDT
$2.27
-$0.06-2.58%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.15M | -2.41M | -6.46M | -5.38M | -3.55M |
| Total Depreciation and Amortization | 190.00K | 452.00K | 5.00K | -- | -- |
| Total Amortization of Deferred Charges | -- | 786.00K | 143.00K | -- | -- |
| Total Other Non-Cash Items | 1.84M | -230.00K | 2.42M | 3.27M | 1.40M |
| Change in Net Operating Assets | -1.21M | -2.42M | 1.90M | 601.00K | -201.00K |
| Cash from Operations | -4.33M | -3.81M | -2.00M | -1.51M | -2.36M |
| Capital Expenditure | -4.00K | 0.00 | -41.00K | -10.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 85.00K | 137.00K | -214.00K | -- |
| Cash from Investing | -4.00K | 85.00K | 96.00K | -224.00K | -- |
| Total Debt Issued | -- | 1.48M | 1.74M | -- | -- |
| Total Debt Repaid | -2.13M | -776.00K | -- | -- | -- |
| Issuance of Common Stock | 8.06M | 3.39M | 1.00K | 113.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 113.00K | -- | -- | -- |
| Cash from Financing | 5.93M | 4.21M | 1.74M | 113.00K | -- |
| Foreign Exchange rate Adjustments | -18.00K | 1.00K | 11.00K | -1.00K | -27.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.58M | 483.00K | -148.00K | -1.63M | -2.38M |